Michel Orsinger reaffirms commitment to Nobel Biocare but will stand for election as regular Board member only
Nobel Biocare Deutschland GmbH
Nobel Biocare (NOBN, SIX Swiss Exchange) is a world leader in innovative restorative and esthetic dental solutions. As a complete solutions provider, Nobel Biocare offers the most comprehensive range of solutions from tooth to root, for single tooth to completely edentulous indications. The solutions portfolio covers dental implants (including the key brands NobelActive(TM) , Brånemark System® and NobelReplace®), individualized prosthetics and equipment (NobelProcera(TM) ), guided surgery solutions and biomaterials. Nobel Biocare has over 2'400 employees and recorded revenue of EUR 569.2 million in 2011. The company is headquartered in Zurich, Switzerland. Production takes place at seven sites located in Canada, Israel, Japan, Sweden, and the US. Nobel Biocare has 34 direct sales organizations.